Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis

Journal of Clinical Pathology

Volumn 51, Issue 1, 1998, Pages 55-61

  Warburton, V J ^a   Everett, S ^b   Mapstone, N P ^a   Axon, A T R ^b   Hawkey, P ^a   Dixon, M F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

cagA; Chronic gastritis; Gastric cancer; Helicobacter pylori; Intestinal metaplasia; Peptic ulcer; vacA

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CHRONIC DISEASE; GASTRITIS; GENOTYPE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; PATHOGENICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0031914577     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.1.55     Document Type: Article

References (30)

1. Figura N, Guglielmetti P, Rossolini, et al. Cytotoxin production by Campylobacter pylori strains isolated fom patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
2. Cover TL, Cao P, Lind CD, et al. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993;61:5008-12.
3. Phadnis SH, Ilver D, Janzon L, et al. Pathological significance and molecular characterisation of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994;62:1557-65.
4. Cover TL, Tummuru MKR, Cao P, et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994;269:10566-73.
5. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995;270:17771-7.
6. Cover TL, Dooley CP, Blaser MJ. Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58:603-10.
7. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61;1799-809.
8. Censini S, Lange C, Xiang Z, et al. Cag A pathogenicity island (PAI) of Helicobacter pylori encodes for type I-specific virulence factors [abstract]. Gut 1996;39(suppl 2):A72.
9. Crabtree JE, Farmery SM, Lindley IJD, et al. CagA cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47;945-50.
10. + Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
11. Ching CK, Wong BC, Kwok E, et al. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996;91:949-53.
12. Crabtree JE, Wyatt JI, Sobala G, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
13. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
15. Ho S-A, Hoyle JA, Lewis FA, et al. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol 1991;29:2543-9.
16. Sobala GM, Axon ATR, Dixon MF. Morphology of chronic antral gastritis: relationship to age, Helicobacter pylori status and peptic ulceration. Eur J Gastroenterol Hepatol 1992; 4:825-9.
17. Lee A, Dixon MF, Danon SJ, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7: 461-5.
18. Atherton JC, Peek RM, Tham KT, et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9.
19. Go MF, Graham DV. Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis. Helicobacter 1996;1:107-11.
20. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997;349:1020-2.
21. Atherton JC, Tham KT, Peek RM, et al. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis 1996;174:552-6.
22. Dixon MF. Helicobacter pylori and peptic-ulceration - histopathological aspects. J Gastroenterol Hepatol 1991;6:125-30.
23. McColl KEL, El-Omar E, Gillen D, et al. H. pylori-induced hypergastrinaemia is related to bacterial CagA status [abstract]. Gut 1997;40(suppl 1):A46.
24. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
25. Beales IL, Crabtree JE, Scunes D, et al. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:645-9.
26. Miehlke S, Bayerdörffer E, Meining A, et al. Identifying persons at risk of gastric cancer. Helicobacter 1997;2(suppl 1):61-6.
27. Ito S, Azuma T, Murakita H, et al. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996;39:800-6.
28. Rautelin H, Sipponen P, Sepppala K, et al. Gastric inflammation and neutrophil-activating and cytotoxin-producing Helicobacter pylori strains. Scand J Gastroenterol 1996;31:639-42.
29. Zhang QB, Nakashabendi M, Mokhashi MS, et al. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996;38: 841-5.
30. Goldstone AR, Quirke P, Dixon MF. Helicobacter pylori and gastric cancer. J Pathol 1996;179:129-37.